Tumor lysis syndrome diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
|||
| (3 intermediate revisions by one other user not shown) | |||
| Line 7: | Line 7: | ||
==Diagnostic Criteria== | ==Diagnostic Criteria== | ||
The diagnosis of tumor lysis syndrome is based on the Cairo–Bishop criteria:<ref name="pmid15384972">{{cite journal| author=Cairo MS, Bishop M| title=Tumour lysis syndrome: new therapeutic strategies and classification. | journal=Br J Haematol | year= 2004 | volume= 127 | issue= 1 | pages= 3-11 | pmid=15384972 | doi=10.1111/j.1365-2141.2004.05094.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15384972}}</ref> | The diagnosis of tumor lysis syndrome is based on the Cairo–Bishop criteria:<ref name="pmid15384972">{{cite journal| author=Cairo MS, Bishop M| title=Tumour lysis syndrome: new therapeutic strategies and classification. | journal=Br J Haematol | year= 2004 | volume= 127 | issue= 1 | pages= 3-11 | pmid=15384972 | doi=10.1111/j.1365-2141.2004.05094.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15384972}}</ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Category}} | |||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Diagnostic criteria}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | |||
Laboratory tumor lysis syndrome | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Abnormality in two or more of the following within 3 days before or 7 days after starting chemotherapy: | |||
:*[[Hyperuricemia]] ≥ 476 μmol/l | :*[[Hyperuricemia]] ≥ 476 μmol/l | ||
:*[[Hyperphosphatemia]] ≥ 2·1 mmol/l (children), x ≥1·45 mmol/l (adults) | :*[[Hyperphosphatemia]] ≥ 2·1 mmol/l (children), x ≥1·45 mmol/l (adults) | ||
:*[[Hyperkalemia]] ≥ 6·0 mmol/l | :*[[Hyperkalemia]] ≥ 6·0 mmol/l | ||
:*[[Hypocalcemia]] ≤ 1·75 mmol/l | :*[[Hypocalcemia]] ≤ 1·75 mmol/l | ||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
Clinical tumor lysis syndrome | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Laboratory tumor lysis syndrome plus one or more of the following: | |||
:*Increase serum [[creatinine]] (1.5 times upper normal limit) | :*Increase serum [[creatinine]] (1.5 times upper normal limit) | ||
:*[[Cardiac arrhythmia]] | :*[[Cardiac arrhythmia]] | ||
:*[[Sudden death]] | :*[[Sudden death]] | ||
:*[[Seizure]] | :*[[Seizure]] | ||
|} | |||
==References== | ==References== | ||
| Line 31: | Line 44: | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
Latest revision as of 17:25, 27 November 2017
|
Tumor lysis syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tumor lysis syndrome diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Tumor lysis syndrome diagnostic criteria |
|
Risk calculators and risk factors for Tumor lysis syndrome diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The diagnosis of tumor lysis syndrome is based on the Cairo–Bishop criteria, which includes uric acid, potassium, phosphorous, and calcium.[1]
Diagnostic Criteria
The diagnosis of tumor lysis syndrome is based on the Cairo–Bishop criteria:[1]
| Category | Diagnostic criteria |
|---|---|
|
Laboratory tumor lysis syndrome |
|
|
Clinical tumor lysis syndrome |
|
References
- ↑ 1.0 1.1 Cairo MS, Bishop M (2004). "Tumour lysis syndrome: new therapeutic strategies and classification". Br J Haematol. 127 (1): 3–11. doi:10.1111/j.1365-2141.2004.05094.x. PMID 15384972.